Gardasil Reimbursement Issues To Be Resolved In Early 2007, Merck Says
Executive Summary
Merck expects reimbursement issues for its human papillomavirus vaccine Gardasil to be resolved by early 2007, Merck Vaccines President Margaret McGlynn said Dec. 12